INVESTIGATION OF THE EFFECT OF LATENT TOXOPLASMA GONDII INFECTION ON STRIATAL NEURODEGENERATION IN THE YAC128 MOUSE MODEL OF HUNTINGTON'S DISEASE

被引:0
|
作者
Jenkins, T. K. [1 ]
Donley, D. W. [2 ]
Fox, J. H. [2 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Wyoming, Laramie, WY 82071 USA
关键词
D O I
10.1136/jim-2017-000663.346
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
346
引用
收藏
页码:210 / 210
页数:1
相关论文
共 50 条
  • [31] EVALUATION OF HIPPOCAMPAL NEUROGENESIS IN YAC128 HUNTINGTON'S DISEASE TRANSGENIC MICE
    Gil-Mohapel, J.
    Simpson, J. M.
    Pouladi, M. A.
    Hayden, M.
    Christie, B. R.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [32] Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease
    Van Raamsdonk, Jeremy M.
    Pearson, Jacqueline
    Murphy, Zoe
    Hayden, Michael R.
    Leavitt, Blair R.
    BMC NEUROSCIENCE, 2006, 7 (1)
  • [33] Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease
    Jeremy M Van Raamsdonk
    Jacqueline Pearson
    Zoe Murphy
    Michael R Hayden
    Blair R Leavitt
    BMC Neuroscience, 7
  • [34] LAQUINIMOD RESCUES STRIATAL, CORTICAL AND WHITE MATTER PATHOLOGY AND RESULTS IN MODEST BEHAVIOURAL IMPROVEMENTS IN THE YAC128 MODEL OF HUNTINGTON'S DISEASE
    Miralles, Marta Garcia
    Hong, Xin
    Caron, Nicholas S.
    Tan, Liang Juin
    Huang, Yihui
    To, Xuan Vinh
    Lin, Rachel Yanping
    Franciosi, Sonia
    Papapetropoulos, Spyros
    Hayardeny, Liat
    Hayden, Michael R.
    Chuang, Kai-Hsiang
    Pouladi, Mahmoud A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A92 - A93
  • [35] Impaired Homeostatic Plasticity in YAC128 Huntington's Disease Mouse Cortical Neurons Rescued by Pridopidine
    Smith-Dijak, Amy
    Mackay, James
    Geva, Michal
    Hayden, Michael
    Raymond, Lynn A.
    NEUROTHERAPEUTICS, 2018, 15 (01) : 258 - 258
  • [36] Screening of Therapeutic Strategies for Huntington's Disease in YAC128 Transgenic Mice
    Gil-Mohapel, Joana M.
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (01) : 77 - 86
  • [37] Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models
    Graham, RK
    Slow, EJ
    Deng, Y
    Bissada, N
    Lu, G
    Pearson, J
    Shehadeh, J
    Leavitt, BR
    Raymond, LA
    Hayden, MR
    NEUROBIOLOGY OF DISEASE, 2006, 21 (02) : 444 - 455
  • [38] Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease
    Huang, Kun
    Kang, Martin H.
    Askew, Caitlin
    Kang, Rujun
    Sanders, Shaun S.
    Wan, Junmei
    Davis, Nicholas G.
    Hayden, Michael R.
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 207 - 215
  • [39] Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease
    Marta Garcia-Miralles
    Xin Hong
    Liang Juin Tan
    Nicholas S. Caron
    Yihui Huang
    Xuan Vinh To
    Rachel Yanping Lin
    Sonia Franciosi
    Spyros Papapetropoulos
    Liat Hayardeny
    Michael R. Hayden
    Kai-Hsiang Chuang
    Mahmoud A. Pouladi
    Scientific Reports, 6
  • [40] Protection by dietary restriction in the YAC128 mouse model of Huntington's disease: Relation to genes regulating histone acetylation and HTT
    Moreno, Cesar L.
    Ehrlich, Michelle E.
    Mobbs, Charles V.
    NEUROBIOLOGY OF DISEASE, 2016, 85 : 25 - 34